This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
OK

Shedding Light on Neural Stimulation

Taking advantage of optoelectronics, we aim to develop personalized neural stimulation systems.

Learn more about us

Innovative solutions

naos

Synergia Medical is pioneering optoelectronics for neural stimulation therapies by developing an innovative, powerful and versatile neural stimulation technological platform.

By doing so, Synergia Medical will improve patients’ quality of life and pave the way to new personalized therapies.

 

Full range of applications

Synergia Medical’s technology could benefit numerous neurological diseases such as chronic pain, Parkinson’s disease, drug-resistant epilepsy, sleep apnoea and depression.

Synergia Medical’s current IP portfolio includes non-metallic encapsulation of neurostimulators, fast-charging wireless system, a custom optical lead, miniaturized photovoltaic cells and an enhanced electrode.

SYNERGIA MEDICAL SUCCESSFULLY IMPLANTS FIRST PATIENTS WITH NAO.VNS™

Brussels, 23 September 2024 – Synergia Medical, a leader in the development of optoelectronic medical devices, is pleased to announce the successful implantation of its groundbreaking NAO.VNS system in the first two patients as part of the AURORA study. These first-in-human implantations took place on September 6, 2024, at Cliniques Universitaires Saint-Luc and UZ Gent. Two weeks after surgery, both patients have fully recovered, allowing the initiation of stimulation therapy as planned.

Learn more

Drug Resistant Epilepsy Therapy

SYNERGIA MEDICAL OBTAINS BELGIUM HEALTH AUTHORITY APPROVAL TO START FIRST IN HUMAN CLINICAL STUDY

Learn more

SYNERGIA MEDICAL WINS PRESTIGIOUS PRIX GALIEN IN BELGIUM FOR ITS OPTOELECTRONIC NEUROSTIMULATOR

Synergia Medical is pleased to announce that they have been awarded the Prix Galien 2023 in Belgium for promising medical devices.

Learn more